Riskpilot← Back to searchSign inGet full accessG.K INVEST ApS
APSActiveCVR 19097471Peder Hvitfeldts Stræde 12Wholesale of pharmaceutical and medical goods · NACE 4646Est. 19960 employees
Revenue 2024
DKK 0
EBITDA margin
—
-11% vs 2023
Equity ratio
19.2%
Financial strength
Net profit 2024
DKK 2,8M
-1% vs 2023
| Revenue | DKK 0 | — |
| EBITDA | DKK -133K | -11% |
| Net profit | DKK 2,8M | -1% |
| Total assets | DKK 27,3M | +2% |
| Equity | DKK 5,2M | +85% |
| Employees | 0 | — |
Legal name
G.K INVEST ApS
CVR number
19097471
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
16. februar 1996
Share capital
DKK 200.000
Employees
0
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af formanden for bestyrelsen eller af direktøren
Company purpose
Selskabets formål er at drive fabrikation, handel, financiering og hermed beslægtet virksomhed.
Address
Peder Hvitfeldts Stræde 12
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -120 | -120 | -120 | -120 | -133 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -120 | -120 | -120 | -120 | -133 |
| Net financials | -839 | -1.049 | 1.777 | 2.974 | 2.954 |
| Profit before tax | -959 | -1.169 | 1.657 | 2.854 | 2.822 |
| Tax | -93 | -2 | 0 | -0 | -0 |
| Net profit | -866 | -1.167 | 1.657 | 2.854 | 2.822 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 27.615 | 26.201 | 24.171 | 26.590 | 27.250 |
| Equity | 998 | -499 | -126 | 2.825 | 5.238 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 26.617 | 26.700 | 24.297 | 23.765 | 22.012 |
| Total debt | 26.617 | 26.700 | 24.297 | 23.765 | 22.012 |
EBITDA margin
-13293800.0%
This company
15.8%
Market median
-84138075% vs market
20202024
Equity ratio
19.2%
This company
38.2%
Market median
-50% vs market
20202024
Return on equity
53.9%
This company
18.4%
Market median
+193% vs market
20202024
Net profit margin
282154700.0%
This company
8.1%
Market median
+3483391258% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
4.20×
This company
0.62×
Market median
-577% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TL Founder | Founder | 1996 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2007 | |
| Former (3) | ||
| Board of Directors | 2000 – 2003 | |
| Board of Directors | 2003 – 2018 | |
| Board of Directors | 1996 – 2000 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2002 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
G.K INVEST ApS 
DET LILLE PALÆ. CHRISTIANSHAVN ApSBoard members of G.K INVEST ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Torsten Lenbroch | Founder | 0 companies |
| Erik Rasmussen | Board of Directors | 0 companies |
| Ole Haslund | Board of Directors | 0 companies |
| Dorthe Lenbroch | Board of Directors | 0 companies |
| Trine Bente Kjems | Board of Directors | 0 companies |